Keyphrases
VAR2CSA
100%
COVID-19
72%
Plasmodium Falciparum
67%
Placental Malaria
60%
Healthcare Workers
55%
Chondroitin Sulfate
52%
Malaria Vaccine
41%
Denmark
35%
Infected Erythrocytes
30%
Malaria
23%
Vaccination
22%
Psoriatic Arthritis
22%
Observational Cohort Study
22%
Receptor-binding Domain
21%
Specific Antibodies
20%
Placenta
20%
Vaccine Candidate
16%
Immune Response
15%
Alhydrogel
14%
Reinfection
14%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
14%
Inhibitory Antibody
13%
2 Receptor
13%
Seroprevalence
13%
Prospective Cohort Study
13%
Adjuvanted
13%
Immunodominant
12%
B-cell Epitope
12%
PfEMP1
12%
Disease Activity
12%
Vaccine Platform
11%
COVID Sequelae
11%
Long COVID
11%
Non-specific Protection
11%
Functional Antibody Responses
11%
Composition System
11%
Functional Insight
11%
Treatment Change
11%
MSP3
11%
TLR4 Agonist
11%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
11%
COVID-19 Risk
11%
Structural Insights
11%
Glurp
11%
GMZ2
11%
Emulsion
11%
Influenza Vaccination
11%
Randomized Controlled Trial
11%
Glucopyranosyl Lipid Adjuvant
11%
Stable Emulsion
11%
Immunology and Microbiology
Vaccine Efficacy
93%
Monospecific Antibody
89%
Plasmodium falciparum
67%
Erythrocyte
33%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Epitope
28%
Receptor Binding
23%
Immune Response
22%
Psoriatic Arthritis
22%
Placenta
20%
Immunoglobulin M
17%
Vaccination Policy
15%
B Cell
13%
Adjuvant
13%
Binding Site
12%
Virus-Like Particle
11%
Humoral Immunity
11%
Seroprevalence
11%
Erythrocyte Membrane
11%
Protein Quaternary Structure
11%
Breakthrough Infection
11%
Lipocalin
11%
Neutrophil
11%
Circulating Tumor Cell
11%
Adoptive Immunity
11%
Epithelial Cell Adhesion Molecule
11%
Agonist
11%
Single-Domain Antibody
11%
Gene Expression System
11%
Antibody Response
11%
TLR4
11%
Intervillous Space
10%
COVID-19
10%
Heavy Chain
8%
Omicron Coronavirus Variant
6%
Immunoglobulin G1
6%
Camelid
5%
Fetus Development
5%
Titer
5%
Plasma Cell
5%
Preclinical Study
5%
